PC SPES in prostate cancer: Critical review of the literature;PC SPES dans le cancer de la prostate : Revue critique de la littérature

Progres en Urologie

Volumn 11, Issue 3, 2001, Pages 428-432

  De La Taille, Alexandre ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

Cancer; Hormone resistant; Phlebitis; Prostate

Indexed keywords

ANTINEOPLASTIC AGENT; HERBACEOUS AGENT; HERBAL PREPARATION PC SPES; HERBAL PREPARATION PC-SPES; PLANT EXTRACT;

CELL DIVISION; HUMAN; MALE; PHYTOTHERAPY; PROSTATE TUMOR; REVIEW;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL DIVISION; DRUGS, CHINESE HERBAL; HUMANS; MALE; PHYTOTHERAPY; PLANT EXTRACTS; PROSTATIC NEOPLASMS;

EID: 0035378024     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. AGARWAL R., WANG Z.Y., MUKHTAR, H. Inhibition of mouse skin tumor-initialing activity of DMBA by chronic oral feeding of glycyrrhizin in drinking water. Nutr. Cancer, 1991, 15, 187-191.
2. DARZYNKIEWICZ Z., TRAGANOS F., WU J.M., CHEN S. Chinese herbal mixture PC SPES in treatment of prostate cancer. Int. J. Oncol., 2000, 17, 729-736.
3. DE LA TAILLE A., BUTTYAN R., HAYEK O., BAGIELLA E., SHABSIGH A., BURCHARDT M., BURCHARDT T., CHOPIN D.K., KATZ A.E. Herbal therapy PC-SPES: in vitro effects and evaluation of its efficacy in 69 patients with prostate cancer. J. Urol., 2000, 164, 1229-1234.
4. DE LA TAILLE A., HAYEK O.R., BURCHARDT M., BURCHARDT T., KATZ A.E. Role of herbal compounds (PC-SPES) in hormone-refractory prostate cancer: two case reports. J. Altem. Complement Med., 2000, 6, 449-451.
5. DE LA TAILLE A., HAYEK O.R., BUTTYAN R., BAGIELLA E., BURCHARDT M., KATZ A.E. Effects of a phytotherapeutic agent, PC-SPES, on prostate cancer: a preliminary investigation on human cell lines and patients. BJU Int., 1999, 84, 845-850.
6. DIPAOLA R.S., ZHANG H., LAMBERT G.H., MEEKER R., LICITRA E., RAFI M.M., ZHU B.T., SPAULDING H., GOODIN S., TOLEDANO M.B., HAIT W.N., GALLO M.A. Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer. N.. Engl. J. Med., 1998, 339, 785-787.
7. FAIR W.R., WHITMORE W.F. Jr. Lecture: Back to the future-the role of complementary medicine in urology. J. Urol., 1999, 162, 411-415.
8. GELIEBTER J., TIWARI R., WU JM. PC-SPES in prostate cancer. N. Engl. J. Med., 1999, 340, 567-568.
9. GHOSH J., MYERS C.E. Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells. Proc. Natl. Acad. Sci. USA. 1998, 95, 13182-13185.
10. HALICKA H.D., ARDELT B., JUAN G., MITTELMAN A., CHEN S., TRAGANOS F., DARZYNKIEWICZ Z. Apoptosis and cell cycle effects induced by extracts of the chinese herbal preparation PC-SPES. Int. J. Oncol., 1997, 11, 437-441
11. HSIEH T., CHEN S.S., WANG X., WU JM. Regulation cf androgen receptor (AR) and prostate specific antigen (PSA) expression in the androgen-responsive human prostate LNCaP cells by ethanolic extracts of the Chinese herbal preparation, PC-SPES. Biochem. Mol. Biol. Int., 1997, 42, 535-544.
12. HSIEH T.C., NG C., CHANG C.C., CHEN S.S., MITTLEMAN A., WU JM. Induction of apoptosis and down-regulation of bcl-6 in mutu I cells treated with ethanolic extracts of the Chinese herbal supplement PC-SPES. Int. J. Oncol., 1998, 13, 1199-1202.
13. KAMEDA H., SMALL E.J., REESE D.M., CORREY M., FROHLICH M.A., BOK R.A., KELLY, W.K. A Phase II Study of PC-SPES, an Herbal Compound, for the Treatment of Advanced Prostate Cancer (PCa). J. Clin. Oncol., 1999, 18, abtsract #1230.
14. KELLIS J.T. JR, VICKERY L.E. Inhibition of human estrogen synthetase (aromatase) by flavones. Science, 1994, 225, 1032-1034.
15. KUBO I. Structural basis for bitterness based on Rabdosia diterpenes. Physiol. Behav., 1994, 56, 1203-1205.
16. KUBOTA T, HISATAKE J, HISATAKE Y, SAID JW, CHEN SS. HOLDEN S, TAGUCHI H, KOEFFLER HP. PC-SPES: a unique inhibitor of proliferation of prostate cancer cells in vitro and in vivo . Prostate., 2000, 42, 163-171.
17. KYO R., NAKAHATA N., SAKAKIBARA I., KUBO M., OHIZUMI Y. Effects of Sho-saiko-to, San'o-shashin-to and Scutellariae Radix on intracellular Ca2+ mobilization in C6 rat glioma cells. Biol. Pharm. Bull., 1998, 21, 1067-1070.
18. LANDIS S.H., MURRAY T., BOLDEN S., WINGO PA. Cancer statistics, 1999. CA Cancer J. Clin., 1999, 49, 8-15.
19. MATSUZAKI Y., KUROKAWA N., TERAI S., MATSUMURA Y., KOBAYASHI N., OKITA K. Cell death induced by baicalein in human hepatocellular carcinoma cell lines. Jpn. J. Cancer Res., 1996, 87, 170-175.
20. MITTELMAN A., TIWARI R.K., CHEN S., GELIEBTER J. Preclinical Analysis of the In Vivo and In Vitro Effects of PC-SPES on Rat Prostate Cancer Cells. J. Clin. Oncol., 1999, 18, abstract #700.
21. MOYAD M.A., PIENTA K.J., MONTIE J.E. Use of PC-SPES, a commercially available supplement for prostate cancer, in a patient with hormone-naive disease. Urology., 1999, 54, 319-323.
22. NAGAO Y, ITO N., KOHNO T., KURODA H., FUJITA E. Antitumor activity of Rabdosia and Teucrium diterpenoids against P 388 lymphocytic leukemia in mice. Chem. Pharm. Bull., 1982, 30, 727-729.
23. NAM R.K., FLESHNER N., RAKOVITCH E., KLOTZ L., TRACHTENBERG J., CHOO R., MORTON G., DANJOUX C. Prevalence and patterns of the use of complementary therapies among prostate cancer patients: an epidemiological analysis. J. Urol., 1999, 161, 1521-1525.
24. OH WK, GEORGE DJ, HACKMANN K, MANOLA J, KANTOFF PW. Activity of the herbal combination, PC-SPES, in the treatment of patients with androgen-independent prostate cancer. Urology, 2001, 57, 122-126.
25. PFEIFER B.L., PIRANI J.F., HAMANN S.R., KLIPPEL K.F. PC-SPES, a dietary supplement for the treatment of hormone-refractory prostate cancer. BJU Int., 2000, 85, 481-485.
26. PORTERFIELD H., UsToo PC-SPES surveys: review of studies and update of previous survey results. Mol. Urol., 2000, 4, 289-292.
27. RAFI M.M., ROSEN R.T., VASSIL A., HO C.T., ZHANG H., GHAI G., LAMBERT G., DIPAOLA R.S. Modulation of bcl-2 and cytotoxicity by licochalcone-A, a novel estrogenic flavonoid. Anticancer Res., 2000, 20, 2653-2658.
28. ROSS R.K., HENDERSON B.E. Do diet and androgens alter prostate cancer risk via a common etiologic pathway? J. Natl. Cancer Inst., 1994, 86, 252-255.
29. SMALL E.J., FROHLICH M.W., BOK R., SHINOHARA K., GROSSFELD G., ROZENBLAT Z., KELLY W.K., CORRY M., REESE D.M. Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer. J Clin Oncol., 2000, 18, 3595-3603.
30. SMITH R.E., DONACHIE A.M., MOWAT A.M. Immune stimulating complexes as mucosal vaccines. Immunol. Cell Biol., 1998, 76, 263-268.
31. TIWARI R.K., GELIEBTER J., GARIKAPATY V.P., YEDAVELLI S.P., CHEN S., MITTELMAN A. Anti-tumor effects of PC-SPES, an herbal formulation in prostate cancer. Int. J. Oncol., 1999, 14, 713-719.
32. WANG S.Y., HSU M.L., HSU H.C., TZENG C.H., LEE S.S., SHIAO M.S., HO C.K. The anti-tumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes. Int. J. Cancer, 1997, 70, 699-703.
33. WILT T.J., ISHANI A., STARK G., MACDONALD R., LAU J., MULROW C. Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review. JAMA, 1998, 280, 1604-1608.